Literature DB >> 15778734

Decreasing the infusion rate reduces the proarrhythmic risk of NS-7: confirming the relevance of short-term variability of repolarisation in predicting drug-induced torsades de pointes.

Elke Detre1, Morten B Thomsen, Jet D Beekman, Karl-Uwe Petersen, Marc A Vos.   

Abstract

1 The rate of infusion has been suggested to be important for drug-induced torsades de pointes (TdP) arrhythmias. We investigated the repolarisation-prolonging effects and proarrhythmic properties of NS-7, a neuroprotective drug in development, using two different infusion rates. 2 A fast (5 min intravenously (i.v.)) escalating dosing regimen (0.3 and 3.0 mg kg(-1), n=4) of NS-7 was investigated in anaesthetised control dogs in sinus rhythm (SR). This was compared to a slow infusion (60 min i.v.) of one dose (3.0 mg kg(-1), n=4) NS-7. The similar dosing regimens were investigated in anaesthetised dogs with chronic, complete AV block (CAVB), an animal model of TdP (n=6). 3 No electrophysiological effects were seen after 0.3 mg kg(-1) NS-7. Fast infusion of 3.0 mg kg(-1) caused prolongation of repolarisation, for example, heart rate corrected QT interval (QT(c)): in SR: 6+/-1%; in CAVB: 10+/-7%, which was accompanied by TdP in three of six CAVB dogs. No TdP were seen in SR dogs. 4 Slow infusion did not cause TdP in the same CAVB dogs, although NS-7 caused repolarisation to prolong with a similar magnitude (QT(c): 12+/-7%) as in the fast-infusion experiment. 5 Short-term variability (STV) is a novel parameter for the prediction of drug-induced TdP analysing the beat-to-beat variability of repolarisation. STV was only increased after the fast infusion in CAVB dogs (2.6+/-0.3 versus 6.0+/-1.4 ms, P<0.05), while there was no increase (2.1+/-0.2 versus 2.5+/-1.0 ms) after the slow infusion of NS-7. 6 Peak plasma concentrations attained were lower in slow (0.5+/-0.1 microg ml(-1) after 50 min) than in fast-infusion regimen (2.1+/-0.4 microg ml(-1) after 5 min; P<0.05). 7 The results support the conclusion that limiting peak plasma concentration by decreasing the rate of infusion of NS-7 reduces the proarrhythmic risk despite comparable prolongation in repolarisation parameters. The relevance of STV in predicting drug-induced TdP was confirmed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15778734      PMCID: PMC1576153          DOI: 10.1038/sj.bjp.0706203

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  37 in total

1.  Instability and triangulation of the action potential predict serious proarrhythmia, but action potential duration prolongation is antiarrhythmic.

Authors:  L M Hondeghem; L Carlsson; G Duker
Journal:  Circulation       Date:  2001-04-17       Impact factor: 29.690

2.  A subpopulation of cells with unique electrophysiological properties in the deep subepicardium of the canine ventricle. The M cell.

Authors:  S Sicouri; C Antzelevitch
Journal:  Circ Res       Date:  1991-06       Impact factor: 17.367

3.  Systemic administration of calmodulin antagonist W-7 or protein kinase A inhibitor H-8 prevents torsade de pointes in rabbits.

Authors:  A Mazur; D M Roden; M E Anderson
Journal:  Circulation       Date:  1999-12-14       Impact factor: 29.690

4.  Neuroprotective effect of NS-7, a novel Na+ and Ca2+ channel blocker, in a focal ischemic model in the rat.

Authors:  Toshiya Katsumata; Hiromi Muramatsu; Hidenori Nakamura; Yutaka Nishiyama; Yasuaki Aoki; Yasuo Katayama
Journal:  Brain Res       Date:  2003-04-18       Impact factor: 3.252

Review 5.  Cellular mechanisms underlying the long QT syndrome.

Authors:  Charles Antzelevitch; Wataru Shimizu
Journal:  Curr Opin Cardiol       Date:  2002-01       Impact factor: 2.161

6.  Enhanced susceptibility for acquired torsade de pointes arrhythmias in the dog with chronic, complete AV block is related to cardiac hypertrophy and electrical remodeling.

Authors:  M A Vos; S H de Groot; S C Verduyn; J van der Zande; H D Leunissen; J P Cleutjens; M van Bilsen; M J Daemen; J J Schreuder; M A Allessie; H J Wellens
Journal:  Circulation       Date:  1998-09-15       Impact factor: 29.690

7.  Effects of blockade of voltage-sensitive Ca(2+)/Na(+) channels by a novel phenylpyrimidine derivative, NS-7, on CREB phosphorylation in focal cerebral ischemia in the rat.

Authors:  K Tanaka; S Nogawa; E Nagata; S Suzuki; T Dembo; A Kosakai; Y Fukuuchi
Journal:  Brain Res       Date:  2000-08-04       Impact factor: 3.252

8.  Divergent proarrhythmic potential of macrolide antibiotics despite similar QT prolongation: fast phase 3 repolarization prevents early afterdepolarizations and torsade de pointes.

Authors:  Peter Milberg; Lars Eckardt; Hans-Jürgen Bruns; Julia Biertz; Shahram Ramtin; Nico Reinsch; Dirk Fleischer; Paulus Kirchhof; Larissa Fabritz; Günter Breithardt; Wilhelm Haverkamp
Journal:  J Pharmacol Exp Ther       Date:  2002-10       Impact factor: 4.030

9.  Arrhythmogenic activities of antiarrhythmic drugs in conscious hypokalemic dogs with atrioventricular block: comparison between quinidine, lidocaine, flecainide, propranolol and sotalol.

Authors:  J Weissenburger; J M Davy; F Chézalviel; O Ertzbischoff; J M Poirier; F Engel; P Lainée; E Penin; G Motté; G Cheymol
Journal:  J Pharmacol Exp Ther       Date:  1991-11       Impact factor: 4.030

10.  Temporal repolarization lability differences among genotyped patients with the long QT syndrome.

Authors:  Kenneth Bilchick; Matti Viitasalo; Lasse Oikarinen; Barry Fetics; Gordon Tomaselli; Heikki Swan; Päivi J Laitinen; Heikki Väänänen; Kimmo Kontula; Ronald D Berger
Journal:  Am J Cardiol       Date:  2004-11-15       Impact factor: 2.778

View more
  6 in total

Review 1.  Drug-induced proarrhythmia: risk factors and electrophysiological mechanisms.

Authors:  Gerrit Frommeyer; Lars Eckardt
Journal:  Nat Rev Cardiol       Date:  2015-07-21       Impact factor: 32.419

2.  No proarrhythmic properties of the antibiotics Moxifloxacin or Azithromycin in anaesthetized dogs with chronic-AV block.

Authors:  M B Thomsen; J D M Beekman; N J M Attevelt; A Takahara; A Sugiyama; K Chiba; M A Vos
Journal:  Br J Pharmacol       Date:  2006-11-06       Impact factor: 8.739

3.  Potentiation of E-4031-induced torsade de pointes by HMR1556 or ATX-II is not predicted by action potential short-term variability or triangulation.

Authors:  G Michael; J Dempster; K A Kane; S J Coker
Journal:  Br J Pharmacol       Date:  2007-10-29       Impact factor: 8.739

4.  Adrenaline reveals the torsadogenic effect of combined blockade of potassium channels in anaesthetized guinea pigs.

Authors:  G Michael; K A Kane; S J Coker
Journal:  Br J Pharmacol       Date:  2008-05-19       Impact factor: 8.739

5.  Inhibition of KCa2 and Kv11.1 Channels in Pigs With Left Ventricular Dysfunction.

Authors:  Carlotta Citerni; Jeppe Kirchhoff; Lisbeth Høier Olsen; Stefan Michael Sattler; Morten Grunnet; Nils Edvardsson; Bo Hjorth Bentzen; Jonas Goldin Diness
Journal:  Front Pharmacol       Date:  2020-05-06       Impact factor: 5.810

Review 6.  The canine chronic atrioventricular block model in cardiovascular preclinical drug research.

Authors:  Vera Loen; Marc A Vos; Marcel A G van der Heyden
Journal:  Br J Pharmacol       Date:  2021-05-04       Impact factor: 9.473

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.